Reports for CHEPLAPHARM ARZNEIMITTEL GMBH
Company Name
CHEPLAPHARM ARZNEIMITTEL GMBH
Totals |
||
Shortage reports |
38 |
|
| Actual shortage: | 4 (11%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (3%) | |
| Resolved: | 33 (87%) | |
Discontinuation Reports |
4 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 4 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
4 (10%) |
|
Overdue reports |
1 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CYTOVENE | 500MG | POWDER FOR SOLUTION | Actual shortage | 2023-02-14 | 2023-05-29 | 184528 |
| ONE-ALPHA | 2MCG | DROPS | Actual shortage | 2023-01-13 | 2023-05-29 | 180961 |
| VALCYTE | 450MG | TABLET | Resolved | 2023-05-02 | 2023-05-25 | 191490 |
| VALCYTE | 50MG | POWDER FOR SOLUTION | Actual shortage | 2023-05-02 | 2023-05-03 | 191497 |
| RIVOTRIL | 0.5MG | TABLET | Resolved | 2022-10-12 | 2023-04-01 | 171577 |
| RIVOTRIL | 2MG | TABLET | Resolved | 2022-10-12 | 2023-04-01 | 171580 |
| FUNGIZONE | 50MG | POWDER FOR SOLUTION | Resolved | 2022-11-10 | 2023-02-14 | 174215 |
| ONE-ALPHA | 2MCG | SOLUTION LIQUID | Resolved | 2022-07-18 | 2022-12-16 | 164812 |
| SUPREFACT | 1MG | SOLUTION | Resolved | 2022-09-12 | 2022-12-08 | 169133 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-08-17 | 2022-09-30 | 166884 |
| VISUDYNE | 15MG | POWDER FOR SOLUTION | Resolved | 2022-07-20 | 2022-08-13 | 165082 |
| SUPREFACT | 1MG | SOLUTION | Resolved | 2022-05-06 | 2022-05-25 | 160170 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-05-09 | 2022-05-25 | 160204 |
| LOSEC | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-12-13 | 2022-05-25 | 151043 |
| RYTHMODAN | 100MG | CAPSULE | Resolved | 2021-11-18 | 2022-03-09 | 149615 |
| SUPREFACT | 1MG | SOLUTION | Resolved | 2021-12-13 | 2022-02-15 | 151046 |
| VISUDYNE | 15MG | POWDER FOR SOLUTION | Resolved | 2020-08-31 | 2022-02-11 | 123386 |
| INHIBACE | 5MG | TABLET | Resolved | 2020-05-13 | 2021-10-19 | 114894 |
| INHIBACE PLUS | 5MG 12.5MG | TABLET | Resolved | 2021-01-04 | 2021-10-19 | 130792 |
| XENICAL | 120MG | CAPSULE | Resolved | 2021-05-13 | 2021-08-10 | 139254 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| XELODA | 150MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176355 |
| XELODA | 500MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176359 |
| SUPREFACT | 100MCG | SOLUTION | Discontinued | 2021-12-13 | 2021-12-13 | 151039 |
| LOSEC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-11-19 | 2021-11-19 | 149669 |
Showing 1 to 4 of 4